Up to 50 percent discontinue within two years
The pitfalls of screening and self-reporting Having a history of an eating disorder doesnt preclude you from using a GLP-1, but experts stress that practitioners should be screening all patients for the potential for recurrence or misuse and closely monitoring them to flag any worsening eating disorder symptoms
TrimRx provides access to both compounded semaglutide ($199/month) and compounded tirzepatide ($349/month), making the most effective weight loss medications affordable and accessible
doi: 10.14336/AD.2025.1165
El Eid L, Reynolds CA, Tomas A, et al
Patients: A total of 1089 insulin-nave adult patients with T2D inadequately controlled on metformin alone (48%) or in combination with sulfonylurea (51%) were randomized to receive once-weekly Ozempic injection 0.5 mg (n=362), once-weekly Ozempic injection 1 mg (n=360), or once-daily insulin glargine U-100 (n=360)